BRPI0414191A - tienoimidazóis substituìdos, processo para sua preparação, seu uso como medicamento ou diagnóstico bem como medicamento contendo os mesmos - Google Patents
tienoimidazóis substituìdos, processo para sua preparação, seu uso como medicamento ou diagnóstico bem como medicamento contendo os mesmosInfo
- Publication number
- BRPI0414191A BRPI0414191A BRPI0414191-1A BRPI0414191A BRPI0414191A BR PI0414191 A BRPI0414191 A BR PI0414191A BR PI0414191 A BRPI0414191 A BR PI0414191A BR PI0414191 A BRPI0414191 A BR PI0414191A
- Authority
- BR
- Brazil
- Prior art keywords
- diseases
- well
- medicine
- treatment
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Tropical Medicine & Parasitology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"TIENOIMIDAZóIS SUBSTITUìDOS, PROCESSO PARA SUA PREPARAçãO, SEU USO COMO MEDICAMENTO OU DIAGNóSTICO BEM COMO MEDICAMENTO CONTENDO OS MESMOS". A presente invenção refere-se a tienoimidazóis substituídos da fórmula (I) ou (II) em que R1 até R4 possuem os significados dados nas reivindicações. Medicamentos contendo compostos deste tipo são úteis na prevenção ou tratamento de diversas doenças. Assim, os compostos podem ser usados, entre outros, para o tratamento de distúrbios respiratórios e do ronco, bem como para o aperfeiçoamento do estímulo respiratório, para o tratamento de doenças agudas e crónicas dos rins e intestino, doenças causadas por casos isquêmicos e/ou de reperfusão bem como por doenças proliferativas ou fibróticas, para o tratamento ou profilaxia de doenças do sistema nervoso central, do metabolismo graxo e do diabetes, da coagulação sangüínea e da infestação por parasitas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10341240A DE10341240A1 (de) | 2003-09-08 | 2003-09-08 | Substituierte Thienoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
PCT/EP2004/009836 WO2005026173A1 (de) | 2003-09-08 | 2004-09-03 | Substituierte thienoimidazole, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0414191A true BRPI0414191A (pt) | 2006-10-31 |
Family
ID=34258478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0414191-1A BRPI0414191A (pt) | 2003-09-08 | 2004-09-03 | tienoimidazóis substituìdos, processo para sua preparação, seu uso como medicamento ou diagnóstico bem como medicamento contendo os mesmos |
Country Status (23)
Country | Link |
---|---|
US (1) | US7179830B2 (pt) |
EP (1) | EP1664058B1 (pt) |
JP (1) | JP2007505035A (pt) |
KR (1) | KR20060069489A (pt) |
CN (1) | CN1845926A (pt) |
AR (1) | AR045600A1 (pt) |
AT (1) | ATE378343T1 (pt) |
AU (1) | AU2004272225A1 (pt) |
BR (1) | BRPI0414191A (pt) |
CA (1) | CA2537695A1 (pt) |
DE (2) | DE10341240A1 (pt) |
GT (1) | GT200400148A (pt) |
IL (1) | IL173918A0 (pt) |
MA (1) | MA28026A1 (pt) |
MX (1) | MXPA06001830A (pt) |
NO (1) | NO20061559L (pt) |
PA (1) | PA8611401A1 (pt) |
PE (1) | PE20050571A1 (pt) |
RU (1) | RU2006111467A (pt) |
SV (1) | SV2005001872A (pt) |
TW (1) | TW200521130A (pt) |
WO (1) | WO2005026173A1 (pt) |
ZA (1) | ZA200601001B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2725209C (en) * | 2008-05-09 | 2016-09-20 | Norbert Beier | Pharmaceutical composition comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction |
FR2993780B1 (fr) * | 2012-07-26 | 2015-02-13 | Assist Publ Hopitaux De Paris | Methode de traitement de la sclerose en plaque |
CN102964354B (zh) * | 2012-11-16 | 2014-08-13 | 江苏先声药业有限公司 | 一类噻吩并咪唑衍生物及其应用 |
TR201910305T4 (tr) * | 2014-04-17 | 2019-07-22 | Pasteur Institut Korea | Viral enfeksiyonları tedavi etmek için bileşikler. |
CN106536502B (zh) | 2014-07-25 | 2019-03-05 | 大正制药株式会社 | 被杂芳基取代的苯基四氢异喹啉化合物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE754935A (fr) | 1969-08-13 | 1971-02-17 | Hoechst Ag | 2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation |
AU636066B2 (en) * | 1990-10-30 | 1993-04-08 | Takeda Chemical Industries Ltd. | Thienoimidazole derivatives, their production and use |
DE4034728A1 (de) * | 1990-10-30 | 1992-05-07 | Schering Ag | Neue thienoimidazolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung |
DE19633966A1 (de) | 1996-08-22 | 1998-02-26 | Hoechst Ag | Phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19945302A1 (de) | 1999-09-22 | 2001-03-29 | Merck Patent Gmbh | Biphenylderivate als NHE-3-Inhibitoren |
DE10015248A1 (de) | 2000-03-28 | 2001-10-04 | Merck Patent Gmbh | Bisamidino-Verbindungen als NHE-3 Inhibitoren |
DE10019062A1 (de) | 2000-04-18 | 2001-10-25 | Merck Patent Gmbh | 2-Guanidino-4-aryl-chinazoline als NHE-3 Inhibitoren |
DE10060292A1 (de) | 2000-12-05 | 2002-06-20 | Aventis Pharma Gmbh | Verwendung substituierter Benzimidazole zur Herstellung eines Medikaments zur Behandlung von Krankheiten, welche durch Inhibierung des Na+/H+-Austauschers beeinflusst werden können und sie enthaltendes Medikament |
DE10163239A1 (de) * | 2001-12-21 | 2003-07-10 | Aventis Pharma Gmbh | Substituierte Imidazolidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie enthaltendes Medikament |
-
2003
- 2003-09-08 DE DE10341240A patent/DE10341240A1/de not_active Withdrawn
-
2004
- 2004-08-02 GT GT200400148A patent/GT200400148A/es unknown
- 2004-08-25 US US10/926,118 patent/US7179830B2/en not_active Expired - Fee Related
- 2004-09-02 PE PE2004000847A patent/PE20050571A1/es not_active Application Discontinuation
- 2004-09-03 AT AT04764791T patent/ATE378343T1/de not_active IP Right Cessation
- 2004-09-03 BR BRPI0414191-1A patent/BRPI0414191A/pt not_active Application Discontinuation
- 2004-09-03 MX MXPA06001830A patent/MXPA06001830A/es not_active Application Discontinuation
- 2004-09-03 DE DE502004005522T patent/DE502004005522D1/de active Active
- 2004-09-03 RU RU2006111467/04A patent/RU2006111467A/ru not_active Application Discontinuation
- 2004-09-03 CA CA002537695A patent/CA2537695A1/en not_active Abandoned
- 2004-09-03 CN CNA2004800256563A patent/CN1845926A/zh active Pending
- 2004-09-03 JP JP2006525114A patent/JP2007505035A/ja active Pending
- 2004-09-03 WO PCT/EP2004/009836 patent/WO2005026173A1/de active IP Right Grant
- 2004-09-03 AU AU2004272225A patent/AU2004272225A1/en not_active Abandoned
- 2004-09-03 KR KR1020067004685A patent/KR20060069489A/ko not_active Application Discontinuation
- 2004-09-03 EP EP04764791A patent/EP1664058B1/de active Active
- 2004-09-06 TW TW093126816A patent/TW200521130A/zh unknown
- 2004-09-06 AR ARP040103198A patent/AR045600A1/es unknown
- 2004-09-08 PA PA20048611401A patent/PA8611401A1/es unknown
- 2004-09-08 SV SV2004001872A patent/SV2005001872A/es not_active Application Discontinuation
-
2006
- 2006-02-03 ZA ZA200601001A patent/ZA200601001B/xx unknown
- 2006-02-23 IL IL173918A patent/IL173918A0/en unknown
- 2006-03-06 MA MA28857A patent/MA28026A1/fr unknown
- 2006-04-06 NO NO20061559A patent/NO20061559L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR045600A1 (es) | 2005-11-02 |
CN1845926A (zh) | 2006-10-11 |
RU2006111467A (ru) | 2006-08-10 |
MXPA06001830A (es) | 2006-05-31 |
SV2005001872A (es) | 2005-03-09 |
NO20061559L (no) | 2006-04-06 |
IL173918A0 (en) | 2006-07-05 |
EP1664058B1 (de) | 2007-11-14 |
AU2004272225A1 (en) | 2005-03-24 |
US7179830B2 (en) | 2007-02-20 |
EP1664058A1 (de) | 2006-06-07 |
PE20050571A1 (es) | 2005-12-02 |
WO2005026173A1 (de) | 2005-03-24 |
US20050075385A1 (en) | 2005-04-07 |
JP2007505035A (ja) | 2007-03-08 |
DE10341240A1 (de) | 2005-04-07 |
DE502004005522D1 (de) | 2007-12-27 |
ZA200601001B (en) | 2007-03-28 |
PA8611401A1 (es) | 2005-03-28 |
ATE378343T1 (de) | 2007-11-15 |
KR20060069489A (ko) | 2006-06-21 |
CA2537695A1 (en) | 2005-03-24 |
TW200521130A (en) | 2005-07-01 |
GT200400148A (es) | 2007-03-22 |
MA28026A1 (fr) | 2006-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | Plant natural product puerarin ameliorates depressive behaviors and chronic pain in mice with spared nerve injury (SNI) | |
BR0307291A (pt) | Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; método para o tratamento e profilaxia de distúrbios diversos e de obesidade em um humano | |
BRPI0514310A (pt) | 8-aminoalcóxi-xantinas substituìdas, método para a produção das mesmas e seu uso como medicamentos | |
BRPI0507309A (pt) | derivados de ácido 7-fenilamino-4quinolon-3-carboxìlico, processos para produção e seu uso como medicamento | |
BR0312697A (pt) | Benzoiluréias substituìdas heterociclicamente, processo para a sua preparação e sua aplicação como medicamento | |
BRPI0610130A2 (pt) | composição farmacêutica, kit e utilização de uma composição | |
BRPI0407907A (pt) | derivados de ácido alcánico substituìdos com aril-cicloaquila, processos para preparação dos mesmos e uso dos mesmos como medicamentos | |
BRPI0407901A (pt) | derivados de diarilcicloalquila, processos para preparação dos mesmos e uso dos mesmos como medicamentos | |
BRPI0414191A (pt) | tienoimidazóis substituìdos, processo para sua preparação, seu uso como medicamento ou diagnóstico bem como medicamento contendo os mesmos | |
BR0311548A (pt) | Tiofenos substituìdos, processo para a sua preparação, sua aplicação como medicamento ou diagnóstico bem como medicamento contendo os mesmos | |
BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
CN106692171B (zh) | 宠物用复方赛拉菌素外用滴剂及其方法和应用 | |
Egwu et al. | The effect of vitamin C at varying times on physiological parameters in rabbits after xylazine anaesthesia. | |
TWI581793B (zh) | 甲胂酸鈉sodium methylarsonate作為病原體醣蛋白抑制劑之醫學新用途。 | |
BRPI0407869A (pt) | derivados de cicloalquila 1,3-substituìdos com grupos ácidos na maioria heterocìclicos; processo para sua preparação e seu uso com medicamento | |
Aleem et al. | History and Traditional uses of Tiryaq (Theriac): An important formulation in Unani medicine | |
Kisani et al. | Comparative local anaesthetic activity of lignocaine, lignocaine-adrenaline and water extracts of Annona muricata during castration in dogs | |
BR0212719A (pt) | Composto, método para produzir um composto, composição farmacêutica que compreende o mesmo, método para tratar uma enfermidade relacionada com os ossos em um paciente e sua utilização | |
Hasan | Study on the effect of Chamomile extract on melatonin hormone levels in subjects suffering from insomnia and anxiety | |
Abuan et al. | EVALUATION OF THE ANTI-INFLAMMATORY ACTIVITY OF THE LINIMENT FROM THE LEAF EXTRACT OF VITEXNEGUNDO FAMILY VERBENACEAE | |
KR100475197B1 (ko) | 스트레스 해소에 효과적인 건강보조식품 및 이의 제조방법 | |
Dhundi et al. | Review on various experimental and clinical studies conducted on Makaradhwaja | |
RU2813777C1 (ru) | Способ лечения пастереллеза крупного рогатого скота | |
RU2559151C2 (ru) | Способ лечения демодекозного блефароконъюнктивита | |
CN102671199B (zh) | 一种能同时溶解地克珠利和球虫酯的溶解剂和一种抗球虫药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |